AWM
AMPH icon

AE Wealth Management’s Amphastar Pharmaceuticals AMPH Stock Holding History

AE Wealth Management’s Portfolio AMPH Stock Details AMPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-19,240
Closed -$406K – 993
2019
Q2 		$406K Buy
19,240
+9,227
+92% +$193K 0.01% 646
2019
Q1 		$205K Buy
+10,013
New +$224K 0.01% 586

Other funds holding AMPH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
VOYA Investment Management
VOYA Investment Management Atlanta, Georgia $96.1B AUM 40.06% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

AE Wealth Management's AMPH Position: Q3 2019 in Review

AE Wealth Management sold out of Amphastar Pharmaceuticals (AMPH) in Q3 2019, closing a stake of 19,240 shares — an estimated $406K sold.

AE Wealth Management first reported a position in AMPH in Q1 2019 and held it in 2 quarters. The position peaked at $406K in Q2 2019. 134 funds tracked by Wall St. Rank hold AMPH as of Q3 2019.

  • AE Wealth Management reported no remaining Amphastar Pharmaceuticals position as of Q3 2019 after selling out during the quarter.
  • AE Wealth Management sold 19,240 Amphastar Pharmaceuticals shares in Q3 2019, an estimated $406K.
  • AE Wealth Management first reported a position in Amphastar Pharmaceuticals in Q1 2019 and held it in 2 quarters.
  • AE Wealth Management's Amphastar Pharmaceuticals position peaked at $406K in Q2 2019.
  • 134 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q3 2019.

Based on AE Wealth Management's 13F filing for Q3 2019, filed 5 Nov 2019.